DK535774A - - Google Patents

Info

Publication number
DK535774A
DK535774A DK535774A DK535774A DK535774A DK 535774 A DK535774 A DK 535774A DK 535774 A DK535774 A DK 535774A DK 535774 A DK535774 A DK 535774A DK 535774 A DK535774 A DK 535774A
Authority
DK
Denmark
Application number
DK535774A
Other languages
Danish (da)
Other versions
DK146974C (da
DK146974B (da
Inventor
D R Macarthur
D E Smith
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK535774(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to DK535774A priority Critical patent/DK146974C/da
Publication of DK535774A publication Critical patent/DK535774A/da
Publication of DK146974B publication Critical patent/DK146974B/da
Application granted granted Critical
Publication of DK146974C publication Critical patent/DK146974C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK535774A 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol DK146974C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GB3745671 1971-08-10
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK392872 1972-08-09
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
ZA7300284 1973-01-15
AU5119173 1973-01-17
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910 1973-01-24
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.
DK535774 1974-10-11
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Publications (3)

Publication Number Publication Date
DK535774A true DK535774A (en:Method) 1975-06-02
DK146974B DK146974B (da) 1984-03-05
DK146974C DK146974C (da) 1984-08-13

Family

ID=36763080

Family Applications (2)

Application Number Title Priority Date Filing Date
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation

Country Status (19)

Country Link
US (1) US4009280A (en:Method)
JP (1) JPS5652001B2 (en:Method)
AT (1) AT333974B (en:Method)
AU (1) AU5119173A (en:Method)
CA (1) CA992461A (en:Method)
DE (1) DE2239091A1 (en:Method)
DK (2) DK131891C (en:Method)
ES (1) ES410910A1 (en:Method)
FI (1) FI56487C (en:Method)
FR (1) FR2150759B1 (en:Method)
GB (1) GB1410588A (en:Method)
IE (1) IE37102B1 (en:Method)
IL (1) IL39990A (en:Method)
LU (1) LU66875A1 (en:Method)
NL (1) NL7210780A (en:Method)
NO (1) NO140747C (en:Method)
SE (1) SE411842B (en:Method)
ZA (1) ZA73284B (en:Method)
ZM (1) ZM11971A1 (en:Method)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042826A (en:Method) * 1973-08-20 1975-04-18
JPS5042827A (en:Method) * 1973-08-20 1975-04-18
JPS5042819A (en:Method) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (en:Method) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
EA003665B1 (ru) † 1997-09-29 2003-08-28 Нектар Терапьютикс Перфорированные микрочастицы и способ их использования
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
CA2433335C (en) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
PL365736A1 (en) * 2001-02-06 2005-01-10 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2415654T3 (es) * 2001-11-20 2013-07-26 Civitas Therapeutics, Inc. Composiciones particuladas mejoradas para suministro pulmonar
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
WO2010010538A2 (en) * 2008-07-24 2010-01-28 L'air Liquide-Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS4826764A (en:Method) 1973-04-09
AU5119173A (en) 1974-07-18
FI56487B (fi) 1979-10-31
GB1410588A (en) 1975-10-22
DK146974C (da) 1984-08-13
DK131891B (da) 1975-09-22
NO140747B (no) 1979-07-30
FR2150759B1 (en:Method) 1975-10-31
US4009280A (en) 1977-02-22
NL7210780A (en:Method) 1973-02-13
ES410910A1 (es) 1976-07-16
DK131891C (da) 1976-02-23
JPS5652001B2 (en:Method) 1981-12-09
LU66875A1 (en:Method) 1973-03-23
FI56487C (fi) 1980-02-11
ATA39073A (de) 1976-04-15
IL39990A0 (en) 1972-09-28
ZA73284B (en) 1973-11-28
NO140747C (no) 1979-11-07
CA992461A (en) 1976-07-06
IL39990A (en) 1977-02-28
FR2150759A1 (en:Method) 1973-04-13
IE37102B1 (en) 1977-05-11
AT333974B (de) 1976-12-27
ZM11971A1 (en) 1973-02-21
DK146974B (da) 1984-03-05
SE411842B (sv) 1980-02-11
DE2239091A1 (de) 1973-02-22

Similar Documents

Publication Publication Date Title
DK129764C (en:Method)
FR2121767B1 (en:Method)
FI53240C (en:Method)
CS172955B2 (en:Method)
FR2128473A1 (en:Method)
FR2122917A5 (en:Method)
FR2128447A1 (en:Method)
FR2127939A5 (en:Method)
CS177831B2 (en:Method)
FR2121621B1 (en:Method)
FR2120637A5 (en:Method)
FR2130221A1 (en:Method)
FR2128782B1 (en:Method)
FR2128481A3 (en:Method)
FR2103151A5 (en:Method)
FR2123318B1 (en:Method)
FR2131102A5 (en:Method)
DE2157161B2 (en:Method)
FR2128622B3 (en:Method)
FR2126920A1 (en:Method)
FR2128878A3 (en:Method)
FR2124198A1 (en:Method)
DE2158884B2 (en:Method)
FR2125824A5 (en:Method)
FR2128784B1 (en:Method)

Legal Events

Date Code Title Description
PBP Patent lapsed